Table 1. Sequences and structural properties of synthetic oligonucleotides.
| Oligonucleotide | Sequence | Description | References |
|---|---|---|---|
| KS-A (6mer) | d(TGGGGT) | Tetramer, telomere | (28–30,59) |
| KS-B (15mer) | d(GGTTGGTGTGGTTGG) | Monomer, thrombin aptamer | (27,31–33) |
| KS-C (12mer) | d(GGGGTTTTGGGG) | Dimer, telomere | (26,34–36,43) |
| KS-D (7mer) | d(GCATGCT) | Dimer, non-GQ | (37,60) |
| KS-E (11mer) | d(GCGGTTTGCGG) | Dimer, fragile X | (3) |
| KS-F (4mer) | d(TAGG) | Tetramer, telomere | (38) |
| KS-G (10mer) | d(GGGTTTTGGG) | Dimer, telomere | (39–41,61) |
| KS-H (28mer) | d(GGGGTTTTGGGGTTTTGGGGTTTTGGGG) | Monomer, telomere | (42,43,62) |
| KS-I (24mer) | d(TTGGGGTTGGGGTTGGGGTTGGGG) | Monomer, telomere | (44) |
| T30695 (16mer) | d(GGGTGGGTGGGTGGGT) | Monomer, anti-HIV | (45) |
| GRO20A (20mer) | d(GGTTTTGGTTTTGGTTTTGG) | Monomer, basket, experimental | (46) |
| GRO23A (23mer) | d(GGGGTTGGGGTGTGGGGTTGGGG) | Mixed basket/chair, experimental | (46) |
| GRO29A (29mer) | d(TTTGGTGGTGGTGGTTGTGGTGGTGGTGG) | Active GRO (proposed dimer) | (20–22) |
| GRO15B (15mer) | d(TTGGGGGGGGTGGGT) | Control GRO | (20–22) |
Underlined bases form loop regions.